The sales forecast for modulators of the genital system and sex hormones in Germany from 2024 to 2028 is projected to remain stable, with a consistent value of 6.5 US Dollars PPP Per Capita annually. Given that the series of forecasts begin from 2024 and forward, the values shown for each year represent a flat trend with no year-on-year variation.
Comparing this to the actual sales in 2023, the data indicates no change in consumption, suggesting that the market has reached a plateau. The last two years have shown steady sales with a year-on-year variation of 0%. Over the last five years, the Compound Annual Growth Rate (CAGR) will likely also reflect no growth or decline, remaining at 0%.
Future trends to watch for include the potential impact of new medical advancements, demographic shifts such as an aging population, and possible regulatory changes which could affect both demand and supply dynamics in this market. Monitoring these factors will be essential for anticipating shifts that may disrupt the current stability.
